Pages that link to "Q30993744"

The following pages link to Direct, controlled synthesis of the nonimmunogenic, hydrophilic polymer, poly(N-(2-hydroxypropyl)methacrylamide) via RAFT in aqueous media. (Q30993744):

Displaying 43 items.

• Multivalent polymers for drug delivery and imaging: the challenges of conjugation (Q27692689) (← links)
• Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model (Q30495832) (← links)
• A deeper insight into the postpolymerization modification of polypenta fluorophenyl methacrylates to poly(n-(2-hydroxypropyl) methacrylamide). (Q30834120) (← links)
• HPMA copolymers: origins, early developments, present, and future (Q33719148) (← links)
• Poly[N-(2-hydroxypropyl)methacrylamide]-Based Tissue-Embedding Medium Compatible with MALDI Mass Spectrometry Imaging Experiments (Q33920041) (← links)
• Macromolecular therapeutics (Q34079574) (← links)
• Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8( ) T cell responses. (Q34145500) (← links)
• Protein, cell and bacterial fouling resistance of polypeptoid-modified surfaces: effect of side-chain chemistry (Q34759124) (← links)
• Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents. (Q35751371) (← links)
• Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates. (Q36126587) (← links)
• Protein-polymer conjugation-moving beyond PEGylation (Q36220152) (← links)
• POLYMERIC BIOMATERIALS AND NANOMEDICINES. (Q36376467) (← links)
• Neutral polymeric micelles for RNA delivery (Q36763827) (← links)
• Tracking and quantifying polymer therapeutic distribution on a cellular level using 3D dSTORM (Q37341499) (← links)
• HYDROGELS FROM SOFT CONTACT LENSES AND IMPLANTS TO SELF-ASSEMBLED NANOMATERIALS. (Q37419778) (← links)
• Beyond oncology--application of HPMA copolymers in non-cancerous diseases. (Q37631869) (← links)
• The use of reversible addition fragmentation chain transfer polymerization for drug delivery systems. (Q37830703) (← links)
• HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release (Q38626421) (← links)
• Synthetic polycations with controlled charge density and molecular weight as building blocks for biomaterials (Q38804726) (← links)
• Synthesis and Properties of Star HPMA Copolymer Nanocarriers Synthesised by RAFT Polymerisation Designed for Selective Anticancer Drug Delivery and Imaging (Q38904632) (← links)
• In vitro evaluation of HPMA-copolymers targeted to HER2 expressing pancreatic tumor cells for image guided drug delivery (Q39095666) (← links)
• Synthesis of maleimide-functionalyzed HPMA-copolymers and in vitro characterization of the aRAGE- and human immunoglobulin (huIgG)-polymer conjugates (Q39226207) (← links)
• Cell Uptake and Trafficking Behavior of Non‐covalent, Coiled‐coil Based Polymer–Drug Conjugates (Q39571512) (← links)
• Protein release from biodegradable polyHPMA-lysozyme conjugates resulting in bioactivity enhancement. (Q39574234) (← links)
• Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer (Q39908819) (← links)
• Self-assembling diblock copolymers of poly[N-(2-hydroxypropyl)methacrylamide] and a beta-sheet peptide (Q41057408) (← links)
• Synthesis of Biodegradable Multiblock Copolymers by Click Coupling of RAFT-Generated HeterotelechelicPolyHPMA Conjugates (Q42066356) (← links)
• Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression (Q42733240) (← links)
• Galactosylated N-2-Hydroxypropyl Methacrylamide-b-N-3-Guanidinopropyl Methacrylamide Block Copolymers as Hepatocyte-Targeting Gene Carriers (Q45721990) (← links)
• Poly(N-(2-Hydroxypropyl) Methacrylamide)-Valproic Acid Conjugates as Block Copolymer Nanocarriers (Q47621039) (← links)
• Metal-Folded Single-Chain Nanoparticle: Nanoclusters and Self-Assembled Reduction-Responsive Sub-5-nm Discrete Subdomains. (Q47943565) (← links)
• A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging (Q48088727) (← links)
• The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment (Q48558433) (← links)
• Directional supracolloidal self-assembly via dynamic covalent bonds and metal coordination. (Q50964419) (← links)
• Thiol-ene “click” reactions and recent applications in polymer and materials synthesis (Q54279480) (← links)
• Building nanostructures using RAFT polymerization (Q57344823) (← links)
• Poly(2-Oxazoline)s - Are They More Advantageous for Biomedical Applications Than Other Polymers? (Q57350479) (← links)
• The direct synthesis of interface-decorated reactive block copolymer nanoparticles via polymerisation-induced self-assembly (Q57366207) (← links)
• Synthesis of poly(N-(2-hydroxypropyl) methacrylamide) brushes by interface-mediated RAFT polymerization (Q57367199) (← links)
• Polymer-protein conjugation via a ‘grafting to’ approach – a comparative study of the performance of protein-reactive RAFT chain transfer agents (Q57368189) (← links)
• Compartmentalization of an ABC triblock copolymer single-chain nanoparticle via coordination-driven orthogonal self-assembly (Q57377398) (← links)
• Mechanism and Kinetics of Dithiobenzoate-Mediated RAFT Polymerization - Status of the Dilemma (Q59272978) (← links)
• Nanosized Delivery Systems for Therapeutic Proteins: Clinically Validated Technologies and Advanced Development Strategies (Q89967538) (← links)